Quantcast
Channel: メディカルプレスセンター QLifePro »ヘルス一般
Browsing all 4010 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Asahi Kasei Offers Pharmaceutical Excipient Ceolus™ with Nitrite...

  TOKYO & NEW YORK & DÜSSELDORF, Germany To contribute to reducing the risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals and nutritional supplements, Asahi Kasei now...

View Article


Image may be NSFW.
Clik here to view.

Endava to Acquire GalaxE Solutions to Boost Its Position in North America...

  LONDON Endava (NYSE: DAVA), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, has entered into a definitive agreement to...

View Article


Image may be NSFW.
Clik here to view.

JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its...

  HYOGO, Japan Thursday, February 29 is Rare Disease Day (“RDD”). RDD activities aim to raise awareness of rare diseases and to improve the quality of life of individuals with rare and intractable...

View Article

Image may be NSFW.
Clik here to view.

Kenai Therapeutics宣布获得8200万美元的A轮融资,以推动针对神经系统疾病的下一代同种异体细胞疗法

  圣迭戈 (美国商业资讯)– Kenai Therapeutics是一家生物科技公司,利用诱导性多能干细胞(iPSC)技术来发现和开发针对神经系统紊乱的同种异体神经元替换细胞疗法,该公司今天宣布获得8200万美元的A轮融资,由Alaska Permanent Fund Corporation、Cure Ventures和The Column Group联合牵头,Euclidean...

View Article

Image may be NSFW.
Clik here to view.

保健市场领导者携手合作:REVIV为The DRIPBaR提供支持

  纽约 (美国商业资讯)– 美国发展最快的静脉注射疗法特许经营机构The...

View Article


Image may be NSFW.
Clik here to view.

ウェルネス市場のリーダー企業による提携:REVIV装備のThe DRIPBaR

  ニューヨーク (ビジネスワイヤ) — 米国で最も急成長中の点滴療法のフランチャイズ企業として認知されているThe...

View Article

Image may be NSFW.
Clik here to view.

PDA India Chapter Annual Meeting – Maintaining Quality & Compliance in...

  HYDERABAD, India PQE Group is excited to join the 2024 PDA India Chapter Annual Meeting in Hyderabad from March 11-15, focusing on key issues in the pharmaceutical and medical device industries. The...

View Article

Image may be NSFW.
Clik here to view.

ETT | iByond™ Asia Division Signs $1.2B Deal with Knightsbridge Bringing...

  PALM BEACH, Fla. ETT | iByond™ and Knightsbridge Group have sealed a monumental deal projected to be worth as much as $1.2 billion, marking a significant stride in advancing digitization and fintech...

View Article


Image may be NSFW.
Clik here to view.

New Data Demonstrate Sunbird Bio’s APEX Diagnostic Test Accurately...

  CAMBRIDGE, Mass. & SINGAPORE Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disorders and...

View Article


Image may be NSFW.
Clik here to view.

ETT | iByond™アジア部門がナイツブリッジと12億ドルの契約を締結し、アジアをはじめとする世界にデジタル化とフィンテックをもたらす

  フロリダ州パームビーチ (ビジネスワイヤ) — ETT | iByond™とナイツブリッジ・グループは、12億ドル相当とみられる巨額契約を締結しました。今回の契約締結により、デジタル化とフィンテック・ソリューションを世界中に推進する取り組みは大きく前進することになります。この提携は、最先端技術を活用し業界全体のイノベーション・変革を推し進めるうえで極めて重要なものです。...

View Article

Image may be NSFW.
Clik here to view.

​​Vyvo Smart Chain Partners with Infineon Technologies to Enhance Data...

  SINGAPORE Vyvo Smart Chain (VSC), a HealthFi ecosystem that rewards health tracking through data monetization on IoT devices, like the Apple Watch, announces its partnership with global...

View Article

Image may be NSFW.
Clik here to view.

Zai Lab Announces Participation in March Investor Conference

  SHANGHAI & CAMBRIDGE, Mass. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference...

View Article

Image may be NSFW.
Clik here to view.

Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study...

  SHANGHAI & CAMBRIDGE, Mass. Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the final overall survival (OS) data from the Phase 3 randomized, double-blind, placebo-controlled...

View Article


Image may be NSFW.
Clik here to view.

The World does not yet Know the Power of Natto: “Natto Power – Japanese...

  TOKYO The Japan natto cooperative society federation (Arakawa-ku, Tokyo; President: Yoshihiro Noro; “JNCSF”) has added new content to and powered up “Natto Power – Japanese Fermented Food Natto, the...

View Article

Image may be NSFW.
Clik here to view.

TauRx 的 LUCIDITY 试验显示 Hydromethylthionine Mesylate(HMTM)具有长达两年的持续认知功能改善。

  阿伯丁,苏格兰 (美国商业资讯)– TauRx Pharmaceuticals Ltd.,阿尔茨海默病(AD)领域中以Tau蛋白为研究核心的全球先锋,在葡萄牙里斯本举行的2024年阿尔茨海默病与帕金森病大会(AD/PD™ 2024)上,分享了其第三阶段LUCIDITY试验的水甲硫噻嗪甲磺酸盐(HMTM)24个月研究数据。 本新闻稿包含多媒体。此处查看新闻稿全文:...

View Article


Image may be NSFW.
Clik here to view.

TauRx、LUCIDITY試験でメシル酸ヒドロメチルチオニン(HMTM)による2年間の持続的な認知機能改善効果を発表

  ABERDEEN, Scotland (ビジネスワイヤ) — アルツハイマー病(AD)におけるタウベース研究の世界的リーダーであるTauRx Pharmaceuticals Ltd.は、メシル酸ヒドロメチルチオニン(HMTM)の第III相LUCIDITY試験における24か月のデータを、ポルトガルのリスボンで開催中の「AD/PD™ 2024 Alzheimer’s &...

View Article

Image may be NSFW.
Clik here to view.

世界尚不知晓纳豆的功效:“Natto Power –日本发酵食品纳豆,美好生活的关键”

  东京 (美国商业资讯)– 日本纳豆合作社联合会(东京荒川区;会长:Yoshihiro Noro;“JNCSF”)在“Natto Power – 日本发酵食品纳豆,美好生活的关键 ”官方网站上添加了新内容并将其启动,该网站去年三月开放,专门介绍日本传统保健食品纳豆。开发的新内容重点关注纳豆的健康益处及其在海外受到的关注。该网站还发布了从科学角度研究纳豆的专家讲座和全面展示纳豆功效的漫画短片。 •...

View Article


Image may be NSFW.
Clik here to view.

Kenai Therapeutics、神経疾患に対する次世代の同種異系細胞療法推進に向けて、8,200万ドルのシリーズA資金調達を発表

  SAN DIEGO (ビジネスワイヤ) — 神経疾患に対する同種異系ニューロン置換細胞療法の発見およびプラットフォーム開発を目的に人工多能性幹細胞(iPSC)技術を活用するバイオテクノロジー企業Kenai Therapeuticsは、このほど8,200万ドルのシリーズA資金調達を発表しました。この資金調達は、アラスカ恒久基金、Cure Ventures、The Column Group...

View Article

Image may be NSFW.
Clik here to view.

Stemson Therapeutics and Bosley Parent Company, Aderans, Sign Exclusive Hair...

  SAN DIEGO Stemson Therapeutics and Aderans Company, the parent company of Bosley® and HAIRCLUB®, today announced an agreement securing Stemson the exclusive global rights to research, develop and...

View Article

Image may be NSFW.
Clik here to view.

Vyvo Smart Chain Announces Listing of $VSC Utility Coin on Gate.io

  SINGAPORE Vyvo Smart Chain (VSC), a HealthFi ecosystem that rewards health tracking through data monetization on IoT devices, like the Apple Watch, announces its official listing on the leading...

View Article
Browsing all 4010 articles
Browse latest View live